These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22935844)

  • 1. L-carnitine treatment in incident hemodialysis patients: the multicenter, randomized, double-blinded, placebo-controlled CARNIDIAL trial.
    Mercadal L; Coudert M; Vassault A; Pieroni L; Debure A; Ouziala M; Depreneuf H; Fumeron C; Servais A; Bassilios N; Bécart J; Assogba U; Allouache M; Bouali B; Luong N; Dousseaux MP; Tezenas-du Montcel S; Deray G
    Clin J Am Soc Nephrol; 2012 Nov; 7(11):1836-42. PubMed ID: 22935844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemia and carnitine supplementation in hemodialyzed patients.
    Kletzmayr J; Mayer G; Legenstein E; Heinz-Peer G; Leitha T; Hörl WH; Kovarik J
    Kidney Int Suppl; 1999 Mar; 69():S93-106. PubMed ID: 10084293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-carnitine supplementation and EPO requirement in children on chronic hemodialysis.
    Aoun B; Bérard E; Vitkevic R; Dehée A; Bensman A; Ulinski T
    Pediatr Nephrol; 2010 Mar; 25(3):557-60. PubMed ID: 19662438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evaluation of postdialysis L-carnitine administration and its effect on weekly requiring doses of rHuEPO in hemodialysis patients.
    Kadiroglu AK; Yilmaz ME; Sit D; Kara IH; Isikoglu B
    Ren Fail; 2005; 27(4):367-72. PubMed ID: 16060121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response.
    Cazzola M; Messinger D; Battistel V; Bron D; Cimino R; Enller-Ziegler L; Essers U; Greil R; Grossi A; Jäger G; LeMevel A; Najman A; Silingardi V; Spriano M; van Hoof A; Ehmer B
    Blood; 1995 Dec; 86(12):4446-53. PubMed ID: 8541533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of L-Carnitine on Mineral Metabolism in the Multicentre, Randomized, Double Blind, Placebo-Controlled CARNIDIAL Trial.
    Mercadal L; Tezenas du Montcel S; Chonchol MB; Debure A; Depreneuf H; Servais A; Bassilios N; Assogba U; Allouache M; Prié D
    Am J Nephrol; 2018; 48(5):349-356. PubMed ID: 30408788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to Erythropoietin Are Associated with Erythropoietin Resistance in Hemodialysis Patients in KwaZulu-Natal (South Africa).
    Benjamin S; Adam J; Naidu Krishna SB; Assounga AG
    Saudi J Kidney Dis Transpl; 2020; 31(5):917-926. PubMed ID: 33229756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnitine treatment improved quality-of-life measure in a sample of Midwestern hemodialysis patients.
    Steiber AL; Davis AT; Spry L; Strong J; Buss ML; Ratkiewicz MM; Weatherspoon LJ
    JPEN J Parenter Enteral Nutr; 2006; 30(1):10-5. PubMed ID: 16387893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a single blind, randomized, placebo-controlled clinical trial to study the effect of intravenous L-carnitine supplementation on health-related quality of life in Indian patients on maintenance hemodialysis.
    Rathod R; Baig MS; Khandelwal PN; Kulkarni SG; Gade PR; Siddiqui S
    Indian J Med Sci; 2006 Apr; 60(4):143-53. PubMed ID: 16679630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral L-carnitine does not decrease erythropoietin requirement in pediatric dialysis.
    Lilien MR; Duran M; Quak JM; Frankhuisen JJ; Schröder CH
    Pediatr Nephrol; 2000 Nov; 15(1-2):17-20. PubMed ID: 11095004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients.
    Brass EP; Adler S; Sietsema KE; Hiatt WR; Orlando AM; Amato A;
    Am J Kidney Dis; 2001 May; 37(5):1018-28. PubMed ID: 11325685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined therapy with L-carnitine and erythropoietin of anemia in chronic kidney failure patients undergoing hemodialysis].
    Wanic-Kossowska M; Kazmierski M; Pawliczak E; Kobelski M
    Pol Arch Med Wewn; 2007; 117(1-2):14-9. PubMed ID: 17642201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of L-carnitine supplementation in hemodialysis patients.
    Veselá E; Racek J; Trefil L; Jankovy'ch V; Pojer M
    Nephron; 2001 Jul; 88(3):218-23. PubMed ID: 11423752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.
    Corwin HL; Gettinger A; Pearl RG; Fink MP; Levy MM; Shapiro MJ; Corwin MJ; Colton T;
    JAMA; 2002 Dec; 288(22):2827-35. PubMed ID: 12472324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Effects of L-Carnitine Against Delayed Graft Function in Kidney Transplant Recipients: A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.
    Jafari A; Khatami MR; Dashti-Khavidaki S; Lessan-Pezeshki M; Abdollahi A; Moghaddas A
    J Ren Nutr; 2017 Mar; 27(2):113-126. PubMed ID: 28065453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Oral L-Carnitine Supplementation on Lipid Profile, Anemia, and Quality of Life in Chronic Renal Disease Patients under Hemodialysis: A Randomized, Double-Blinded, Placebo-Controlled Trial.
    Emami Naini A; Moradi M; Mortazavi M; Amini Harandi A; Hadizadeh M; Shirani F; Basir Ghafoori H; Emami Naini P
    J Nutr Metab; 2012; 2012():510483. PubMed ID: 22720143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter study.
    Kurz Ch; Marth Ch; Windbichler G; Lahousen M; Medl M; Vavra N; Sevelda P
    Gynecol Oncol; 1997 Jun; 65(3):461-6. PubMed ID: 9190976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effect of intravenous l-carnitine on quality of life in chronic hemodialysis patients.
    Semeniuk J; Shalansky KF; Taylor N; Jastrzebski J; Cameron EC
    Clin Nephrol; 2000 Dec; 54(6):470-7. PubMed ID: 11140808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma carnitine profile during chronic renal anemia treatment with recombinant human erythropoietin.
    Debska-Slizień A; Owczarzak A; Kunicka D; Lysiak-Szydłowska W; Rutkowski B
    Int J Artif Organs; 2003 Jan; 26(1):33-8. PubMed ID: 12602467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Reducing L-Carnitine Supplementation on Carnitine Kinetics and Cardiac Function in Hemodialysis Patients: A Multicenter, Single-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Sugiyama M; Hazama T; Nakano K; Urae K; Moriyama T; Ariyoshi T; Kurokawa Y; Kodama G; Wada Y; Yano J; Otsubo Y; Iwatani R; Kinoshita Y; Kaida Y; Nasu M; Shibata R; Tashiro K; Fukami K
    Nutrients; 2021 May; 13(6):. PubMed ID: 34073024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.